Technology Strategy Board projects honoured at awards

02 Dec 2008

Two research and development projects co-funded by the Technology Strategy Board have gained national recognition at today's Medical Futures Innovation Awards in London.

One of the finalists in the Orthopaedic Innovation Awards category is a Technology Strategy Board-funded project managed by Regentec.  The project has developed a polymer technology to make liquid injectable bone for use as bone graft material during surgery.

A second finalist, in the Ophthalmology Innovation Awards section, is for a project that has developed a new imaging device and software package for the detection and management of eye disease is one of the finalists.  This collaborative research and development project involved Qinetiq, Gloucestershire Hospital, Gloucestershire Eye Therapy, Davin Optronics, Heriott Watt University and Screen Eye.

Other projects reaching the finals included two from companies which have previously benefitted from Technology Strategy Board project investment - Orthomimetics and Biointeractions Ltd.         

Iain Gray, Chief Executive of the Technology Strategy Board, which sponsored the Best Business Proposition Award at the Medical Futures Innovation Awards, said: "We are delighted to see innovative medical technologies, in which the Technology Strategy Board has invested, achieving recognition in these nationally-important awards.  Through its investment in ground-breaking research and development, the Technology Strategy Board is helping to bring together the UK's world class expertise to develop and exploit innovative technologies in a key area for the UK - and which have global potential."

Download pdf of full press release including notes for editors

This video requires flash version 7 or higher to play.

Last updated on Monday 15 December 2008 at 12:20

More like this

Copyright © 2013